Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGF for alveolar ridge preservation after simple exodontia in anterior maxilla
2019-001167-75Phase 3Active
- Sponsor
- BTI I MAS D
- Start
- Jun 2019
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised trial of PRGF-Endoret in alveolar process atrophy (2 arms), sponsored by BTI I MAS D. Primary endpoint: Bone formation by histomorphometric analysis. Started Jun 2019; status: active.
02
Drugs
PRGF-Endoret
03
Conditions
alveolar process atrophy
Beyond the preview
Go deeper on 2019-001167-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001167-75.